Biogen and Eisai release new Alzheimer’s drug data that may support wider uptake
Biogen Inc. and Eisai Co. late Wednesday released new data on their Alzheimer’s treatment Leqembi that may ultimately help bolster uptake of the drug. Weekly treatment with an experimental subcutaneous formulation of Leqembi, which could be easier to administer than the currently approved biweekly…
#biogeninc #eisaico #leqembi #biogen #jefferies #iv #eisaiesalf #boston #elilillycos #lly